Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study

Table 3

Adverse events following transarterial chemoembolization (TACE) (48 treatments in 30 patients).

Variable	𝑛
Number of TACE/patient (mean, range)	1.6 (1–7)
Adverse events (%)
None	20 (42)
Yes	28 (58)
Minor events, number of TACE (%)	24 (50)
Pain in right upper quadrant	18 (38)
Nausea/emesis	7 (15)
Chemical arteritis	5 (10)
Corticosteroids-related diabetes unbalances	2 (4)
Ischemic hepatitis	2 (4)
Leucocytosis	1 (2)
Fever	1 (2)
Allergic reaction	1(2)
Major events, number of TACE (%)	7 (15)
Ischemic cholecystitis	2 (4)
Transient acute hepatic failure	2 (4)
Thrombosis of superficial femoral artery	1 (2)
Splenic infarction	1 (2)
Ischemic atrophy of the left hepatic lobe	1 (2)
Acute renal failure	1 (2)*
Spontaneous bacterial peritonitis	1 (2)*
Sepsis	1 (2)*
Death	1 (2)*

*Those events occurred in the same patient.